파렌키마바이오텍 주식회사

{
  "address": "부산광역시 부산진구",
  "ceo_name": "서수길",
  "certificate": [
    {
      "cert_number": "20200107129",
      "changes": "",
      "disclosure_date": "2020-05-29",
      "first_cert_date": "2020-05-29",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2020-05-29 ~ 2022-05-28"
    },
    {
      "cert_number": "20220511010023",
      "changes": "",
      "disclosure_date": "2022-05-11",
      "first_cert_date": "2020-05-29",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-05-29 ~ 2025-05-28"
    },
    {
      "cert_number": "20250520010014",
      "changes": "",
      "disclosure_date": "2025-05-20",
      "first_cert_date": "2020-05-29",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-05-29 ~ 2028-05-28"
    }
  ],
  "company_name": "파렌키마바이오텍 주식회사",
  "financials": {
    "2022": {
      "capital_stock": 247467000,
      "cost_of_sales": 0,
      "current_assets": 1200308000,
      "current_liabilities": 729109000,
      "gross_profit": 85000000,
      "net_income": -590198000,
      "net_income_bs": -590198000,
      "non_current_assets": 22343000,
      "non_current_liabilities": 21395000,
      "non_operating_expenses": 40216000,
      "non_operating_income": 6626000,
      "operating_profit": -556608000,
      "revenue": 85000000,
      "sga_expenses": 641608000,
      "total_assets": 1222651000,
      "total_equity": 472147000,
      "total_liabilities": 750504000
    },
    "2023": {
      "capital_stock": 247467000,
      "cost_of_sales": 0,
      "current_assets": 593759000,
      "current_liabilities": 1014433000,
      "gross_profit": 0,
      "net_income": -850628000,
      "net_income_bs": -850628000,
      "non_current_assets": 60552000,
      "non_current_liabilities": 18358000,
      "non_operating_expenses": 46007000,
      "non_operating_income": 20183000,
      "operating_profit": -824804000,
      "revenue": 0,
      "sga_expenses": 824804000,
      "total_assets": 654311000,
      "total_equity": -378480000,
      "total_liabilities": 1032791000
    },
    "2024": {
      "capital_stock": 249641000,
      "cost_of_sales": 0,
      "current_assets": 323777000,
      "current_liabilities": 1197984000,
      "gross_profit": 0,
      "net_income": -531204000,
      "net_income_bs": -531204000,
      "non_current_assets": 73658000,
      "non_current_liabilities": 9108000,
      "non_operating_expenses": 53046000,
      "non_operating_income": 3433000,
      "operating_profit": -481591000,
      "revenue": 0,
      "sga_expenses": 481591000,
      "total_assets": 397435000,
      "total_equity": -809657000,
      "total_liabilities": 1207092000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "999,000,000",
      "changes": "999,000,000",
      "date": "2022-04-05"
    },
    {
      "amount": "999,988,000",
      "changes": "999,988,000",
      "date": "2022-04-05"
    }
  ],
  "phone": "051-893-****",
  "source": "pg_migration"
}

{
  "address": "부산 부산진구 복지로 75 (개금동, 인제대학교의과대학 중개의학연구실) 201호",
  "employee_count": 2,
  "establishment_date": "20181001",
  "source": "pg_migration",
  "workplace_name": "파렌키마바이오텍주식회사"
}